首页 | 本学科首页   官方微博 | 高级检索  
     

血管紧张素(1-7)通过抑制JAK/STAT信号通路对抗高糖诱导的人脐静脉内皮细胞损伤
引用本文:陈健芳,陈景福,陈巍,徐峥嵘,李潮生,王振花,张耀,陈军. 血管紧张素(1-7)通过抑制JAK/STAT信号通路对抗高糖诱导的人脐静脉内皮细胞损伤[J]. 中国病理生理杂志, 2017, 33(3): 481-488. DOI: 10.3969/j.issn.1000-4718.2017.03.016
作者姓名:陈健芳  陈景福  陈巍  徐峥嵘  李潮生  王振花  张耀  陈军
作者单位:1. 广东医科大学, 广东 湛江 524023;
2. 宝安人民医院心血管内科, 广东深圳 518101;
3. 东莞市第三人民医院心血管内科, 东莞市心血管研究所, 广东 东莞 523326
基金项目:广东省深圳市宝安区社会公益项目(No.2015009)
摘    要:目的:研究血管紧张素(1-7)[Ang-(1-7)]能否通过抑制JAK/STAT信号通路对抗高糖诱导的人脐静脉内皮细胞(HUVECs)损伤。方法:CCK-8检测细胞存活率;Western blot法检测内皮细胞JAK2、STAT3、pJAK2、p-STAT3、cleaved caspase-3和内皮型一氧化氮合酶(e NOS)的蛋白水平;Hoechst 33258染色荧光显微镜照相法检测内皮细胞凋亡数量;DCFH-DA染色荧光显微镜照相法检测内皮细胞内活性氧簇(ROS)的水平。结果:应用高糖(40 mmol/L)处理HUVECs 12~48 h能明显上调JAK2的磷酸化水平,于24 h达最高峰;在24~48 h能明显上调STAT3的磷酸化水平,于36 h最高;在12~24 h能明显上调cleaved caspase-3的表达,在3~48 h随着时间延长,e NOS的表达逐渐降低。2μmol/L的Ang-(1-7)或20μmol/L的JAK/STAT通路抑制剂AG490预处理0.5 h可显著抑制由高糖引起的内皮细胞损伤,表现为p-STAT3、p-JAK2及cleaved caspase-3蛋白水平降低、细胞存活率及e NOS表达升高,细胞凋亡数量和胞内ROS生成减少。结论:Ang-(1-7)能通过抑制JAK/STAT通路对抗高糖诱导的人脐静脉内皮细胞损伤。

关 键 词:血管紧张素(1-7)  JAK/STAT信号通路  高糖  人脐静脉内皮细胞  AG490  
收稿时间:2016-10-12

Angiotensin (1-7) protects human umbilical vein endothelial cells against high glucose-induced injury by inhibiting JAK/STAT signaling pathway
CHEN Jian-fang,CHEN Jing-fu,CHEN Wei,XU Zheng-rong,LI Chao-sheng,WANG Zhen-hua,ZHANG Yao,CHEN Jun. Angiotensin (1-7) protects human umbilical vein endothelial cells against high glucose-induced injury by inhibiting JAK/STAT signaling pathway[J]. Chinese Journal of Pathophysiology, 2017, 33(3): 481-488. DOI: 10.3969/j.issn.1000-4718.2017.03.016
Authors:CHEN Jian-fang  CHEN Jing-fu  CHEN Wei  XU Zheng-rong  LI Chao-sheng  WANG Zhen-hua  ZHANG Yao  CHEN Jun
Affiliation:1. Guangdong Medical University, Zhanjiang 524023, China;
2. Department of Cardiology, People's Hospital of Baoan, Shenzhen 518101, China;
3. Department of Cardiology, The Third Hospital of Dongguan City, Cardiovascular Institute of Dongguan City, Dongguan 523326, China
Abstract:AIM: To investigate whether angiotensin (1-7) protects human umbilical vein endothelial cells (HUVECs) against high glucose-induced injury by inhibiting JAK/STAT signaling pathway. METHODS: The cell viability was examined by CCK-8 assay. The expression levels of JAK2, STAT3, p-JAK2, p-STAT3, cleaved caspase-3 and endothelial nitric oxide synthase (eNOS) were detected by Western blot. The number of apoptotic cells was observed by photofluorography with Hoechst 33258 nuclear staining. The intracellular levels of reactive oxygen species (ROS) were tested by DCFH-DA staining followed by photofluorography. RESULTS: Expose of the HUVECs to high glucose (40 mmol/L) for different time significantly increased phosphorylation level of JAK2 which reached the peak at 24 h. The protein level of p-STAT3 significantly increased at 24~48 h and reached the peak at 36 h. The expression of cleaved caspasep-3 was significantly up-regulated at 12~24 h, and the expression of eNOS gradually decreased at 3~48 h with prolongation of time. Pretreatment of the HUVECs with Ang-(1-7) at 2 μmol/L or AG490 (an inhibitor of JAK/STAT pathway) at 20 μmol/L for 0.5 h before exposure of the cells to high glucose for 24 h markedly attenuated high glucose-induced injury of the HUVECs, by increasing the cell viability and eNOS expression, and decreasing the apoptotic cells, ROS production and cleaved caspase-3 expression. Furthermore, pretreatment with Ang-(1-7) for 0.5 h also decreased the protein levels of p-JAK2 and p-STAT3. CONCLUSION: Ang-(1-7) protects the HUVECs against high glucose-induced injury by inhibiting JAK/STAT signaling pathway.
Keywords:Angiotensin (1-7)  JAK/STAT signaling pathway  High glucose  Human umbilical vein endothelial cells  AG490
本文献已被 CNKI 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号